ARENSIA Exploratory Medicine, LLC

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Acute myeloid leukaemia1 trial
• Lung cancer1 trial
• Ovarian cancer1 trial

Phase

• Phase 1/21 trial
• Phase 2/31 trial

Status

• Active, not recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Gilead Sciences1 trial
• Moleculin Biotech, Inc.1 trial

Running trials

• Recruiting

  L-Annamycin for Injection in Combination With Cytarabine Injection as Second Line Therapy for Remission Induction in Adult Subjects With Refractory/Relapsed AML

  NCT06788756· Phase 2/3· Moleculin Biotech, Inc.· Source

  Contact: Alla Petrenko

• Recruiting

  FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

  NCT06303505· Phase 1/2· Gilead Sciences· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Acute myeloid leukaemia1 recruiting